The ANSM, via its director general, responded to our mail on March 31.
REMINDER: we are currently the only victims' association still sitting on the ANSM for Lutéran and Lutényl, whereas there were many for Androcur (but they disappeared from the meetings!).
The association insisted on receiving a written response.
We were heard and received a comprehensive answer to women's questions regarding meningiomas and progestins, beyond the medications already studied, Androcur, Lutéran, and Lutényl.
You have the answer in PDF format and complete here:
https://amavea.org/…/courrier-amavea-meningiomes-et…
We were answered on all the points addressed:
- Risk of meningiomas and progestins
- Mirena and risk of meningioma
- Possibility to go back to prescriptions of more than 24 months
– Adverse event reporting website
: https://signalement.social-sante.gouv.fr/psig_ihm_utilisateurs/index.html#/accueil
